Anybody here have any idea of the market potential for OMS302? I listened to the Jefferies presentation and they have data on the number of procedures (3.6M annually in the US), but gave no sense on what this means in potential $. I can't imagine they could charge more than say $300 per procedure for a drug of this type, but even at that price it is a billion $ drug?
I think the risk reward is quite good. simple and effective, I was also thinking around 300 for the procedure. with that many procedures even if they only had 30% of the market they would do very well. the efficacy is outstanding.